Programmed cell death ligand 1 gamma-delta chimeric antigen receptor T cell therapy (Kiromic)

N/A

Report date: 2024/04/29 11:39:07

Base Information

Drug NameProgrammed cell death ligand 1 gamma-delta chimeric antigen receptor T cell therapy (Kiromic)
Drug Alias NameALEXIS-PRO-1 Procel™ALEXIS-PRO-1 ProcelProgrammed cell death protein 1 gamma-delta chimeric antigen receptor T cell therapy (Kiromic)ProcelPD1-GDT CAR T-cell therapy (Kiromic) +[14] 
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionAnti-PD-1T lymphocyte replacementsImmunologic cytotoxicity
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesKiromic Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesKiromic Biopharma Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A